Fed. Circ. Agrees Prenatal DNA Test Patent Doesn't Hold Up
The written description for a fetal DNA testing patent owned by Stanford University researchers doesn't include a key part of its method of detecting Down syndrome, rendering the patent invalid, the Federal...To view the full article, register now.
Already a subscriber? Click here to view full article